
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
UNC5H1 CRISPR/Cas9 KO Plasmid (h) | sc-405369 | 20 µg | $397.00 |
UNC5A encodes the netrin receptor UNC5H1, a transmembrane guidance molecule that directs axon navigation and neuronal positioning through ligand-dependent signaling. UNC5H1 participates in netrin-1–mediated attractive/repulsive cue integration and can influence cytoskeletal dynamics, adhesion, and migratory behavior via downstream Rho family GTPase and MAPK-linked pathways. Beyond neurodevelopment, UNC5H1-associated signaling has been connected to regulation of apoptosis and epithelial–mesenchymal-like cellular programs, supporting roles in tissue patterning and homeostasis. Dysregulated UNC5A/UNC5H1 expression or altered pathway coupling has been reported in studies of neurodevelopmental disorders and cancer biology, where it is used as a mechanistic node to probe guidance-to-survival cross-talk.
UNC5H1 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the UNC5A gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the UNC5A together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the UNC5A open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish UNC5H1 protein expression.
This CRISPR knockout system enables efficient generation of UNC5A-deficient cell models for investigation of UNC5H1 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.